Literature DB >> 28798515

Genomic testing as a tool to optimise drug therapy.

Andrew A Somogyi1, Elizabeth Phillips2.   

Abstract

Entities:  

Keywords:  abacavir; adverse drug reaction; allopurinol; azathioprine; carbamazepine; pharmacogenomics; phenytoin

Year:  2017        PMID： 28798515      PMCID： PMC5478394          DOI： 10.18773/austprescr.2017.027

Source DB:  PubMed          Journal:  Aust Prescr        ISSN： 0312-8008


× No keyword cloud information.
  7 in total

1.  Fatal azathioprine toxicity.

Authors:  David Liew; Claire Keith; Jane Booth; Dhineli Perera
Journal:  Aust Prescr       Date:  2017-06-01

2.  The current and future state of pharmacogenomics medical education in the USA.

Authors:  Tracey J Nickola; James S Green; Arthur F Harralson; Travis J O'Brien
Journal:  Pharmacogenomics       Date:  2012-09       Impact factor: 2.533

3.  HLA-B*5801: a genetic susceptibility to allopurinol-induced DRESS.

Authors:  Augustine N Mugwagwa; Roy Fischer; Izwan Zailan
Journal:  Med J Aust       Date:  2016-03-07       Impact factor: 7.738

Review 4.  Pharmacogenomics in the clinic.

Authors:  Mary V Relling; William E Evans
Journal:  Nature       Date:  2015-10-15       Impact factor: 49.962

5.  HLA-B*5701 screening for hypersensitivity to abacavir.

Authors:  Simon Mallal; Elizabeth Phillips; Giampiero Carosi; Jean-Michel Molina; Cassy Workman; Janez Tomazic; Eva Jägel-Guedes; Sorin Rugina; Oleg Kozyrev; Juan Flores Cid; Phillip Hay; David Nolan; Sara Hughes; Arlene Hughes; Susanna Ryan; Nicholas Fitch; Daren Thorborn; Alastair Benbow
Journal:  N Engl J Med       Date:  2008-02-07       Impact factor: 91.245

6.  Pharmacogenetic tests: the need for a level playing field.

Authors:  Munir Pirmohamed; Dyfrig A Hughes
Journal:  Nat Rev Drug Discov       Date:  2013-01       Impact factor: 84.694

7.  Standardizing terms for clinical pharmacogenetic test results: consensus terms from the Clinical Pharmacogenetics Implementation Consortium (CPIC).

Authors:  Kelly E Caudle; Henry M Dunnenberger; Robert R Freimuth; Josh F Peterson; Jonathan D Burlison; Michelle Whirl-Carrillo; Stuart A Scott; Heidi L Rehm; Marc S Williams; Teri E Klein; Mary V Relling; James M Hoffman
Journal:  Genet Med       Date:  2016-07-21       Impact factor: 8.822
  7 in total
  4 in total

1.  Pharmacogenomics and drug therapy.

Authors:  Shyan Goh
Journal:  Aust Prescr       Date:  2018-02-01

2.  Drugs and genetics.

Authors:  Thomas Polasek
Journal:  Aust Prescr       Date:  2017-10-03

3.  Nitrosative Stress and Lipid Homeostasis as a Mechanism for Zileuton Hepatotoxicity and Resistance in Genetically Sensitive Mice.

Authors:  Dahea You; Lascelles E Lyn-Cook; Daniel M Gatti; Natalie Bell; Philip R Mayeux; Laura P James; William B Mattes; Gary J Larson; Alison H Harrill
Journal:  Toxicol Sci       Date:  2020-06-01       Impact factor: 4.849

4.  Retail genetics.

Authors:  Ken Harvey; Basia Diug
Journal:  Aust Prescr       Date:  2017-06-01
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.